Legal Opinion
Classen Immunotherapies, Inc. v. Biogen Idec
District Court, D. Maryland
Decided August 27, 2013No. Civil No. WDQ-04-2607Published
1Opinion of the Court
MEMORANDUM OPINION
WILLIAM D. QUARLES, JR., District Judge.
Classen Immunotherapies, Inc. (“Classen”) sued Biogen Idee (“Biogen”) and GlaxoSmithKline (“GSK”) (collectively the “defendants”) for patent infringement. Pending is claim construction. On June 7, 2013, the Court held a claim construction hearing.
I. Background1 '
Classen is the assignee of John B. Classen, M.D. (“Dr. Classen”) inventor of the patents in suit. Biogen has licensed patents “relating to recombinant hepatitis B virus vaccines.” ECF No. 207 ¶ 6. GSK and its affiliates manufacture and market several vaccines, including…
2Cases cited22 opinions
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- Herbert Markman and Positek, Inc. v. Westview Instruments, Inc. And Althon Enterprises, Inc.Court of Appeals for the Federal Circuit · 1995
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
- Sri International v. Matsushita Electric Corporation of America and Matsushita Electric Industrial Co., Ltd.Court of Appeals for the Federal Circuit · 1985
17 more not listed; retrieve them via the Exa API.